MedWatch is the FDA's safety information and adverse event reporting program. It has three forms:
- Form FDA 3500: voluntary reports by health professionals.
- Form FDA 3500B: voluntary reports by consumers and patients, in plain language.
- Form FDA 3500A: mandatory reports, used by IND sponsors, manufacturers, distributors, importers and user facilities.
For a company, the form is not the whole story. Under 21 CFR 314.80(g), postmarketing safety reports must be submitted electronically in a format the FDA can process, unless the FDA grants a temporary waiver. Under 21 CFR 312.32, an IND safety report may be a narrative, a Form 3500A or an electronic report, and a CIOMS I form may be used for foreign cases; since April 1, 2026, the FDA requires IND safety reports of serious and unexpected suspected adverse reactions to be sent electronically, using E2B(R3), to its Adverse Event Monitoring System (AEMS, formerly FAERS).